Cerner Enviza is an American healthcare company that provides data, analytics, and research to the life sciences industry, with a particular focus on oncology and rare diseases. Kantar Health was acquired by Bain Capital in 2019, [ 2 ] which sold it to the Cerner Corporation on April 1, 2021, and was subsequently renamed Cerner Enviza.
On June 8, 2022, Oracle’s acquisition of Cerner became official. With the addition of Cerner to Oracle Health’s portfolio, we will advance how health happens by providing secure and reliable solutions that deliver better health insights and people-centric experiences.
The team developed the name Cerner Enviza, a coined word based on ‘envision’ that conveys the remarkable clarity the new operating unit would bring to healthcare’s most important decisions. In support of the new unit’s purpose, we created a brand identity system with a fresh logo, color palette, photography, iconography and much more.
Cerner Enviza is the combination of Kantar Health Division’s rich life sciences expertise including all its past capabilities, now brought together with Cerner’s collection of real-world data (RWD) and technology to accelerate the discovery, development and delivery of extraordinary therapeutics by harnessing the power of everyday healthcare.
Cerner Enviza | 41,103 followers on LinkedIn. Cerner Enviza is now a part of Oracle – helping bring remarkable clarity to healthcare's most important decisions. | Oracle has been a leader...
Cerner Enviza | 41,099 followers on LinkedIn. Cerner Enviza is now a part of Oracle – helping bring remarkable clarity to healthcare's most important decisions. | Oracle has been a leader...
May 5, 2022 · Cerner Enviza aims to accelerate the discovery, development and delivery of extraordinary insights and therapies to improve everyday health for all people globally. By combining decades of innovation, life sciences knowledge and collaborative research, Cerner Enviza provides data-driven solutions and expertise that helps bring remarkable ...